Is it Time to Dump Tandem Diabetes Care Inc (TNDM) Stock After it Has Risen 14.70% in a Week?

Tandem Diabetes Care Inc (TNDM) stock is higher by 14.70% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Tandem Diabetes Care Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TNDM!

See Full TNDM Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With TNDM Stock Today?

Tandem Diabetes Care Inc (TNDM) stock is trading at $128.66 as of 1:33 PM on Wednesday, Sep 8, a drop of -$0.74, or -0.57% from the previous closing price of $129.40. Volume today is 669,089 compared to average volume of 577,539. The stock has traded between $127.31 and $130.73 so far today.

More About Tandem Diabetes Care Inc

Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a user's pocket. The t:flex Insulin Delivery System is used by customers with greater insulin needs. The t:slim G4 Insulin Delivery system is a continuous glucose monitoring enabled pump with a touch screen. Tandem Diabetes also sells pump-related supplies and accessories. Pump sales contribute the majority of revenue. The firm generates virtually all of its revenue in the United States. Click Here to get the full Stock Report for Tandem Diabetes Care Inc stock.